EXELIXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.7 USD | +0.72% |
|
+5.24% | -1.21% |
| 04-12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
| 04-11 | Barclays Downgrades Exelixis to Equalweight From Overweight, Price Target is $25 | MT |
Chart calendar Exelixis, Inc.
7b2c2ebd68d45797.77YyviTbNF85tFLJzUOQyEQIjKRttO2gs5eZ3G6Onq8.uI4Hyk6New5T0mS8njKkoC172_cE-tjL3uWtnj39-5i30UaHabINBQrtHw~108bfe8f1ebf8e36677173fda64fea16
Upcoming events on Exelixis, Inc.
Past events on Exelixis, Inc.
| 13/03/2024 14:45 | Barclays Global Healthcare Conference |
| 12/03/2024 13:20 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 15:30 | TD Cowen Health Care Conference |
| 13/02/2024 17:40 | Oppenheimer Healthcare Life Sciences Conference |
| 08/02/2024 14:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 06/02/2024 22:00 | Q4 2023 Earnings Call |
| 06/02/2024 21:05 | Q4 2023 Earnings Release |
| 25/01/2024 15:55 | ASCO Genitourinary Cancers Symposium |
| 09/01/2024 00:30 | JPMorgan Healthcare Conference |
| 12/12/2023 14:00 | R&D Day |
| 28/11/2023 16:00 | Piper Sandler Healthcare Conference |
| 10/11/2023 20:35 | International Kidney Cancer Symposium |
| 01/11/2023 21:00 | Q3 2023 Earnings Call |
| 01/11/2023 20:05 | Q3 2023 Earnings Release |
| 22/10/2023 07:40 | European Society for Medical Oncology Congress |
| 12/09/2023 18:35 | Morgan Stanley Global Healthcare Conference |
| 08/09/2023 16:00 | Wells Fargo Healthcare Conference |
| 01/08/2023 22:00 | Q2 2023 Earnings Call |
| 01/08/2023 21:05 | Q2 2023 Earnings Release |
| 14/06/2023 00:00 | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 968 967 0.07% | 988 988 -0.06% | 1 435 1 340 7.05% | 1 611 1 602 0.58% | 1 830 1 829 0.06% | 1 911 |
|
EBITDA Million USD | Released Forecast Spread | 378 350 8.05% | 119 117 2.2% | 300 207 45.02% | 222 320 -30.61% | 197 215 -8.7% | 478 |
|
EBIT Million USD | Released Forecast Spread | 369 352 4.98% | 110 96,8 13.73% | 287 193 48.36% | 201 229 -12.18% | 171 184 -7.18% | 406 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 398 378 5.37% | 131 121 7.91% | 294 204 44.03% | 234 233 0.62% | 258 252 2.39% | 483 |
|
Net income Million USD | Released Forecast Spread | 321 304 5.76% | 112 99,7 12.12% | 231 161 43.27% | 182 189 -3.58% | 208 199 4.36% | 375 |
|
EPS USD | Released Forecast Spread | 1,02 0,97 5.61% | 0,35 0,32 10.95% | 0,72 0,49 47.94% | 0,56 0,55 1.25% | 0,65 0,61 6.85% | 1,24 |
| Announcement Date | 25/02/20 | 10/02/21 | 17/02/22 | 07/02/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 451 356 26.81% | 356 363 -1.99% | 419 392 6.91% | 412 403 2.04% | 424 419 1.24% | 409 423 -3.28% | 470 445 5.6% | 472 473 -0.31% | 480 478 0.36% | 460 | 481 | 488 | 478 | 459 |
|
EBITDA Million USD | Released Forecast Spread | 88,3 111 -20.47% | -42,1 -4,80 -777.75% | 88,3 79,5 11.11% | 136 | 132 | 31,7 | 120 | |||||||
|
EBIT Million USD | Released Forecast Spread | 117 27,3 327.61% | 83,2 54,4 53.02% | 83,7 77,9 7.44% | 82,6 79,6 3.73% | -48,1 -52,6 8.66% | 28,8 59,3 -51.39% | 77,9 60,0 29.8% | -17,6 31,4 -155.92% | 81,8 73,3 11.61% | 80,0 | 102 | 93,6 | 136 | 96,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 118 30,0 293.31% | 85,2 58,6 45.34% | 88,5 75,8 16.81% | 92,0 83,7 9.99% | -31,4 -38,4 18.09% | 48,3 67,9 -28.94% | 100 67,5 48.73% | 5,82 47,3 -87.7% | 103 87,0 18.41% | 101 | 126 | 110 | 141 | 114 |
|
Net income Million USD | Released Forecast Spread | 95,2 24,8 284.25% | 68,6 46,5 47.43% | 70,7 60,2 17.37% | 73,2 64,5 13.48% | -30,2 -37,0 18.38% | 40,0 50,1 -20.12% | 81,2 51,1 58.9% | 1,04 34,7 -97% | 85,5 73,6 16.22% | 80,4 | 97,3 | 89,5 | 106 | 89,8 |
|
EPS USD | Released Forecast Spread | 0,29 0,06 350.03% | 0,21 0,14 46.85% | 0,22 0,19 16.4% | 0,23 0,19 23.21% | -0,09 -0,14 34.78% | 0,12 0,15 -20% | 0,25 0,16 59.89% | 0,00 0,09 - | 0,27 0,22 20.51% | 0,24 | 0,31 | 0,30 | 0,39 | 0,35 |
| Announcement Date | 17/02/22 | 10/05/22 | 09/08/22 | 01/11/22 | 07/02/23 | 09/05/23 | 01/08/23 | 01/11/23 | 06/02/24 | - | - | - | - | - |
More events
Past sector events for Exelixis, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EXEL Stock
- Calendar Exelixis, Inc.
